|
|
Article: New U.S. Clinical Studies Show ACCOLATE To be Effective and Well-Tolerated Therapy for Asthma
- Article from:
- PR Newswire
- Article date:
- September 22, 1997
CopyrightCOPYRIGHT 1997 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
BERLIN, Sept. 22 /PRNewswire/ -- New data from three U.S. and seven European studies of the asthma medication ACCOLATE(R) (zafirlukast)(l) continue to demonstrate that the drug is effective and well tolerated among patients in clinical studies. Results of the clinical studies were presented the evening of September 21, at the European Respiratory Society (ERS) annual meeting held in Berlin, Germany, September 20-24, 1997.
ACCOLATE, an oral medication from Zeneca Pharmaceuticals for the preventive and chronic treatment of asthma in adults and children 12 years of age and older, is a leukotriene receptor antagonist (LTRA) licensed in a number of countries, ...